alalevonadifloxacin
- Generic Name
- alalevonadifloxacin
Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 48
- Registration Number
- NCT02244827
- Locations
- 🇺🇸
University of Miami,Division of Clinical Pharmacology, Miami, Florida, United States
Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers
Phase 1
Completed
- Conditions
- Qt Interval, Variation in
- Interventions
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 80
- Registration Number
- NCT02217930
- Locations
- 🇺🇸
Phase 1 unit : Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath